| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland
NK cells can kill MHC-different or MHC-deficient but not syngeneic MHC-expressing target cells. This MHC class I-specific tolerance is acquired during NK cell development. MHC recognition by murine NK cells largely depends on clonally distributed Ly49 family receptors, which inhibit NK cell function upon ligand engagement. We investigated whether these receptors play a role for the development of NK cells and provide evidence that the expression of a Ly49 receptor transgene on developing NK cells endowed these cells with a significant developmental advantage over NK cells lacking such a receptor, but only if the relevant MHC ligand was present in the environment. The data suggest that the transgenic Ly49 receptor accelerates and/or rescues the development of NK cells which would otherwise fail to acquire sufficient numbers of self-MHC-specific receptors. Interestingly, the positive effect on NK cell development is most prominent when the MHC ligand is simultaneously present on both hemopoietic and nonhemopoietic cells. These findings correlate with functional data showing that MHC class I ligand on all cells is required to generate functionally mature NK cells capable of reacting to cells lacking the respective MHC ligand. We conclude that the engagement of inhibitory MHC receptors during NK cell development provides signals that are important for further NK cell differentiation and/or maturation.
This article has been cited by other articles:
|
|
 |
|
  A. W. MacFarlane IV, T. Yamazaki, M. Fang, L. J. Sigal, T. Kurosaki, and K. S. Campbell Enhanced NK-cell development and function in BCAP-deficient mice Blood, July 1, 2008; 112(1): 131 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Benoit and R. Tan Xenogeneic beta2-Microglobulin Substitution Alters NK Cell Function J. Immunol., August 1, 2007; 179(3): 1466 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Taki, S. Nakajima, E. Ichikawa, T. Saito, and S. Hida IFN Regulatory Factor-2 Deficiency Revealed a Novel Checkpoint Critical for the Generation of Peripheral NK Cells J. Immunol., May 15, 2005; 174(10): 6005 - 6012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Johansson, H. Hall, J. Bjorklund, and P. Hoglund Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro Int. Immunol., January 1, 2004; 16(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Lee, A. Zafer, Y. de Repentigny, R. Kothary, M. L. Tremblay, P. Gros, P. Duplay, J. R. Webb, and S. M. Vidal Transgenic Expression of the Activating Natural Killer Receptor Ly49H Confers Resistance to Cytomegalovirus in Genetically Susceptible Mice J. Exp. Med., February 17, 2003; 197(4): 515 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-W. Wang, J. M. Howson, T. Ghansah, C. Desponts, J. M. Ninos, S. L. May, K. H. T. Nguyen, N. Toyama-Sorimachi, and W. G. Kerr Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation Science, March 15, 2002; 295(5562): 2094 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ioannidis, J. Zimmer, F. Beermann, and W. Held Cre Recombinase-Mediated Inactivation of H-2Dd Transgene Expression: Evidence for Partial Missing Self-Recognition by Ly49A NK Cells J. Immunol., December 1, 2001; 167(11): 6256 - 6262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Young, M. Uhrberg, J. H. Phillips, L. L. Lanier, and P. Parham Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL J. Immunol., March 15, 2001; 166(6): 3933 - 3941. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
